Please login to the form below

Not currently logged in
Email:
Password:

Bayer veteran joins Aurinia as CEO

Stephen Zaruby spent 20 years at German pharma company
Aurinia Stephen Zaruby

Aurinia Pharmaceuticals has appointed Stepen Zaruby as president and CEO.

His career includes a 20-year stint at German company Bayer, including spells managing its domestic and international anti-infectives, quinolone and hospital/surgical business franchises.

Mmost recently he served as president at ZymoGenetics until its acquisition by Bristol-Myers Squibb in 2010. Since then he has worked as an independent consultant in life sciences.

Commenting on his latest appointment, Zaruby said he was looking forward to the future for kidney-focused Aurinia as it looks to launch its first drug.

“Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said.

Aurinia's chair Dr Richard Glickman said: “Stephen is a seasoned leader with a strong track record of delivering strategic direction and operational excellence to both established and emerging life sciences companies.

“He is exceptionally qualified to help us build our voclosporin franchise and sharpen our execution."

11th November 2013

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics